Cultural Adaptation of Drug Treatment for DJJ Youth

• Sponsor: Medical University of South Carolina (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT06003725
• Collaborator: (none)
• Enrollment: 55
• Location: 1
• Arm: 1
• Anticipated Duration (Months): 56
• Patients Per Site Per Month: 1

Study Details

Study Description

Brief Summary

This project aims to improve the understanding of the impact of Ethnic and Racial Discrimination (ERD) on adolescent alcohol and other drug use (AOD) within the Black Justice-Involved Youth (JIY) population. Individual interviews with Black JIY and focus groups with parents and guardians of Black JIY and community members who support change and reform in the justice community for Black JIY will be conducted.

Condition or Disease	Intervention/Treatment	Phase
Substance Use	Behavioral: Culturally Adapted Adolescent Substance Use Treatment	N/A

Detailed Description

Black JIY are overrepresented in the criminal justice system due to institutional racism and discrimination. The General Strain Theory posits that high levels of ethnic and racial discrimination (ERD), paired with elevated levels of witnessing or experiencing police brutality, places Black JIY at unique risk of increased alcohol and other drug use (AOD) as a means of coping with stressful events. Black JIY report engaging in comorbid alcohol and cannabis use to achieve temporary respite from discrimination-induced stress. While JIY engage in higher rates of comorbid alcohol and cannabis use compared to non-justice-involved youth, overall, Black JIY are less likely to be diverted to substance use treatment programs, less likely to engage in care after being released on probation, less likely to benefit from substance use treatment in terms of reduced risk of recidivism, and are more adversely affected by early onset of AOD activity than White JIY. To date, no known adolescent substance use treatment directly addresses ERD, the increased risk of AOD due to ERD, or explicitly presents tools on how to appropriately respond to AOD and discrimination distress among Black JIY. To address this problem, the investigator's research program aspires to improve the understanding of the impact of ERD on adolescent AOD within the Black JIY population. Individual interviews with Black JIY and focus groups with guardians of Black JIY and community members will be conducted. Data will be used to culturally adapt an adolescent substance use intervention. The culturally adapted intervention will then be piloted with 30 Black JIY.

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 55 participants
• Allocation: N/A
• Intervention Model: Sequential Assignment
• Intervention Model Description: Individual interviews with Black justice-involved youth (JIY) and focus groups with guardians of Black JIY and community members will be conducted. Data from focus groups and interviews will be used to inform the cultural adaptation of an evidence-based adolescent substance use treatment. The cultural adapted treatment will then be piloted with 30 Black JIY for feasibility and acceptability.Individual interviews with Black justice-involved youth (JIY) and focus groups with guardians of Black JIY and community members will be conducted. Data from focus groups and interviews will be used to inform the cultural adaptation of an evidence-based adolescent substance use treatment. The cultural adapted treatment will then be piloted with 30 Black JIY for feasibility and acceptability.
• Masking: None (Open Label)
• Masking Description: No masking
• Primary Purpose: Other
• Official Title: The Cultural Adaptation of an Alcohol and Other Drug Use Treatment for Black Justice Involved Youth
• Actual Study Start Date: Sep 30, 2022
• Anticipated Primary Completion Date: Apr 30, 2027
• Anticipated Study Completion Date: May 30, 2027

Arms and Interventions

Arm	Intervention/Treatment
Experimental: ADAP-ITT Phase 8 Phase 8 consists of piloting the culturally adapted CYT intervention with 30 Black JIY to examine feasibility and acceptability.	Behavioral: Culturally Adapted Adolescent Substance Use Treatment; The Cannabis Youth Treatment Series (CYT) (MET/CBT12 model) aims to reduce alcohol and cannabis use.; Other Names: Cannabis Youth Treatment Series

Outcome Measures

Primary Outcome Measures

1. Feasibility and Acceptability [After study completion, an average of 3 months]

   Participants will complete feasibility and acceptability questionnaires and provide qualitative data on likes and dislikes about the intervention, delivery, session structure, and content.

Secondary Outcome Measures

1. Change in substance use [Baseline, after each study visit, at study completion, up to 3 months post-intervention, an average of 6 months.]

   Participants will complete urinalysis

2. Change in substance use [Baseline, after each study visit, at study completion, up to 3 months post-intervention, an average of 6 months.]

   Participants will complete timeline followback

3. Change in discrimination distress [baseline, after study completion, and up to 3 months post-intervention, an average of 6 months.]

   Participants will complete a discrimination distress assessment measure

Eligibility Criteria

Criteria

• Ages Eligible for Study: 12 Years to 17 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

For Focus Groups and Interviews:

Black JIY Participants:

Inclusion Criteria:

• Between the ages of 12-17, 2) identify as Black or African American, and 3) on community probation.

Exclusion Criteria:

• Will be excluded if they do not have parental consent to participate.

For Focus Groups and Interviews:

Adult Participants

Inclusion Criteria:

• A guardian of JIY

• An advocate (someone who supports change and reform in the justice community) for Black JIY.

Exclusion Criteria:

• Will be excluded if they do not provide consent to participate.

For pilot feasibility study:

Black JIY Participants:

Inclusion Criteria:

• Between the ages of 12 and 17

• Identify as Black or African American

• Be on community probation

• Meet criteria for alcohol, cannabis, or other drug misuse as defined by the DSM 5

• Be experiencing at least 1 problem related to AOD;

• The frequency of AOD must be weekly use over a 3-month period

Exclusion Criteria:

• Will be excluded if they do not have parental consent to participate

• Parole violation

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Medical University of South Carolina	Charleston	South Carolina	United States	29425

Sponsors and Collaborators

• Medical University of South Carolina

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Brittany Bryant, Assistant Professor, Medical University of South Carolina
• ClinicalTrials.gov Identifier: NCT06003725
• Other Study ID Numbers: Pro00122199
• First Posted: Aug 22, 2023
• Last Update Posted: Aug 22, 2023
• Last Verified: Aug 1, 2023

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Brittany Bryant, Assistant Professor, Medical University of South Carolina: Substance use; substance misuse; adolescent; cultural adaptation
• Additional relevant MeSH terms: Substance-Related Disorders

Study Results

No Results Posted as of Aug 22, 2023